18th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2020)

  • 03-05 Dec 2020
  • Hilton Hotel Universal City, Los Angeles, CA, United States

Description

The 18th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2020) is dedicated to insulin resistance, obesity, diabetes, related Kidney, cardiovascular disease and fatty liver morbidity.

The 18th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2020) covers topics such as:

  • The effect of lipotoxicity and the pathophysiology of CVD
  • The relationship between diabetes, obesity, and congestive heart failure
  • The roles of diabetes in the development of micro & macrovascular conditions: kidney disease, retinopathy, neuropathy, CVD and strokes
  • The role of obesity in the development of cardiometabolic conditions
  • The role of incretins in the management of diabetes, obesity, and related complications
  • Comprehensive management of diabetes, through addressing obesity, hypertension, dyslipidemia and hyperglycemia
  • The role of SGLT2i & GLP1ra for primary prevention of cardiovascular morbidity & mortality in patients with T2D
  • The evidence supporting the use of SGLT2 inhibitors and GLP1ra`s to reduce cardiovascular morbidity & mortality in patients with T2D and established CVD
  • Fatty liver disease and its relationship to diabetes and CVD
  • The role of PCSK9 inhibitors in preventing CV morbidity in people with established ASCVD
  • The impact on clinical practice of recent CVD, CHF & CKD outcome trials
  • The pathogenesis of liver and muscle insulin resistance, the role of adipose tissue and of the mitochondria in hyperglycemia and ASCVD
  • Best practices for the prevention and management of CHF
  • The impact on clinical practice of lipid CV outcome trials, including IMPROVE -IT, FOURIER, REDUCE -IT, ODYSSEY-Outcomes
  • The role of Coagulation and new anti-coagulation agents in prevention of CVD and CVA
  • The Cardiorenal Syndrome
  • Reducing morbidity and mortality through being able to match the correct medications to the appropriate patients

The 18th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2020) brings together:

  • Endocrinologists
  • Cardiologists
  • Oncologists
  • Gastroenterologists
  • Diabetologists
  • Internists
  • Pediatricians
  • OBGYNs
  • Nurse practitioners
  • Dietitians
  • Pharmacists
  • Other health care professionals

The 18th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2020) will be held in Los Angeles, CA, United States on 03-05 Dec 2020.

Venue

Hilton Hotel Universal City
555 Universal Hollywood Drive,
Los Angeles,
California,
United States
View Hotels near Venue
Free cancellation available

More Details

Prices:
450-650 US Dollar   (Early registration date: 01 Nov 2020)
Exhibition:
Included
Organizer:
TMIOA - The Metabolic Institute of America
Website:
Abstract submission deadline:
26 Oct 2020

Future Events

  • 18th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2020) - 03-05 Dec 2020, Hilton Hotel Universal City, Los Angeles, CA, United States (30831)
  • 19th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2021) - 2021, Hilton Hotel Universal City, Los Angeles, CA, United States (30832)

Past Events

  • 17th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2019) - 05-07 Dec 2019, Hilton Hotel Universal City, Los Angeles, CA, United States (15938)
  • 16th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2018) - 29 Nov - 01 Dec, 2018, Hilton Hotel Universal City, Los Angeles, CA, United States (4901)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Other Events with Similar Categories

Featured Conferences & Exhibitions